Get the Stockscreener App
401.87
0.58%
2.32
After Hours:
401.87
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Chemed Corp stock is traded at $401.87, with a volume of 297.63K.
It is up +0.58% in the last 24 hours and down -15.08% over the past month.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
See More
Previous Close:
$399.55
Open:
$403.7
24h Volume:
297.63K
Relative Volume:
1.58
Market Cap:
$5.53B
Revenue:
$2.53B
Net Income/Loss:
$265.24M
P/E Ratio:
21.88
EPS:
18.3669
Net Cash Flow:
$325.48M
1W Performance:
-1.47%
1M Performance:
-15.08%
6M Performance:
-9.98%
1Y Performance:
-31.88%
1-Day Range:
$399.38
$408.74
1-Week Range:
$397.77
$409.33
52-Week Range:
$385.00
$623.61
Chemed Corp Stock (CHE) Company Profile
Name
Chemed Corp
Sector
Industry
Phone
(513)762-6690
Address
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
401.87 | 5.50B | 2.53B | 265.24M | 325.48M | 18.37 |
|
HCA
Hca Healthcare Inc
|
532.97 | 119.10B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
227.63 | 19.54B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.79 | 12.71B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
209.71 | 12.11B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
192.42 | 11.64B | 17.36B | 1.51B | 849.25M | 23.15 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Jefferies | Buy → Hold |
| Sep-02-25 | Upgrade | Jefferies | Hold → Buy |
| Jul-25-25 | Initiated | Jefferies | Hold |
| Mar-11-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-19 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Buy |
| Oct-12-18 | Initiated | BofA/Merrill | Buy |
| Aug-28-17 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jul-27-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-02-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-26-15 | Reiterated | Oppenheimer | Outperform |
| Oct-26-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-22-15 | Reiterated | Oppenheimer | Outperform |
| Jul-27-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-19-15 | Reiterated | Oppenheimer | Outperform |
| Sep-23-14 | Reiterated | Oppenheimer | Outperform |
| Jun-10-14 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-01-14 | Reiterated | Oppenheimer | Outperform |
| Sep-10-13 | Reiterated | Deutsche Bank | Hold |
| Mar-04-11 | Reiterated | Barclays Capital | Underweight |
| Feb-17-11 | Reiterated | Oppenheimer | Outperform |
| Feb-17-11 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Chemed Corp Stock (CHE) Latest News
Chemed (NYSE:CHE) CEO Sells $806,360.00 in Stock - MarketBeat
Chemed (CHE) CEO Kevin McNamara sells 2,000 shares, retains 93,719 - Stock Titan
Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference - Bluefield Daily Telegraph
First Trust Advisors LP Grows Stock Position in Chemed Corporation $CHE - MarketBeat
Chemed: Expanding Hospice Reach Through Strategic Certificate Of Need Wins In Florida! - Smartkarma
Chemed (NYSE:CHE) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
Technical Reactions to CHE Trends in Macro Strategies - Stock Traders Daily
Chemed Corporation $CHE Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
CHE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Chemed Corporation $CHE Shares Purchased by Bahl & Gaynor Inc. - MarketBeat
Chemed Corporation Receives 'Hold' Rating from Analysts - National Today
Chemed Corp. Stock Hits Day Low of $385 Amid Price Pressure - Markets Mojo
Chemed Corp (CHE) Stock Analysis: Navigating A Stable Healthcare Giant with 8% Upside Potential - DirectorsTalk Interviews
Chemed Corporation (NYSE:CHE) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Chemed Corp. Faces Weak Start with 14% Gap Down Amid Market Concerns - Markets Mojo
Chemed Corp. Stock Plummets to New 52-Week Low at $385.00 - Markets Mojo
CHE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Chemed Q4 Earnings Call Highlights - Yahoo Finance
CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash - Yahoo Finance
Chemed Corporation (NYSE:CHE) Q4 2025 Earnings Call Transcript - Insider Monkey
RBC Capital cuts Chemed stock rating on Roto-Rooter margin concerns By Investing.com - Investing.com South Africa
RBC Capital cuts Chemed stock rating on Roto-Rooter margin concerns - Investing.com
Earnings call transcript: Chemed Corp misses Q4 2025 estimates, stock drops By Investing.com - Investing.com South Africa
Chemed Corp stock hits 52-week low at 397.05 USD By Investing.com - Investing.com Australia
Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewswire Inc.
Why Chemed (CHE) Shares Are Plunging Today - Yahoo Finance
Chemed (CHE) Q4 2025 Earnings Call Transcript - AOL.com
Earnings call transcript: Chemed Corp misses Q4 2025 estimates, stock drops - Investing.com
VITAS Takes a Punch in Q4 2025, Expects Brighter 2026 - Hospice News
Chemed (NYSE:CHE) Reaches New 52-Week Low After Earnings Miss - MarketBeat
BofA downgrades Chemed stock rating on weaker Roto-Rooter outlook By Investing.com - Investing.com Canada
BofA downgrades Chemed stock rating on weaker Roto-Rooter outlook - Investing.com
Chemed Corp stock hits 52-week low at 397.05 USD - Investing.com
Chemed Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
TD Asset Management Inc Has $135.14 Million Stake in Chemed Corporation $CHE - MarketBeat
Chemed: Fourth Quarter Earnings Overview - Bitget
Chemed (NYSE:CHE) Updates FY 2026 Earnings Guidance - MarketBeat
Chemed Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Chemed (NYSE:CHE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops 14.7% - Finviz
Chemed: Q4 Earnings Snapshot - Barchart.com
Chemed Corp. Profit Retreats In Q4 - Nasdaq
Chemed Corp (CHE) Releases Q4 2025 Earnings: Revenue Slightly Down, EPS Miss and Operating Cash Decline - Quiver Quantitative
Chemed Corporation Reports Fourth Quarter 2025 Financial Results, Highlights Performance in VITAS and Roto-Rooter Segments - Quiver Quantitative
Hospice and plumbing under one roof: how Chemed plans to lift 2026 profits - Stock Titan
Chemed earnings on deck: Can hospice rebound ease Roto-Rooter woes? - Investing.com India
Chemed earnings on deck: Can hospice rebound ease Roto-Rooter woes? By Investing.com - Investing.com South Africa
Chemed (CHE) To Report Earnings Tomorrow: Here Is What To Expect - Finviz
Chemed Corp (CHE) Stock Analysis: Healthcare Service Leader Eyes 16.85% Potential Upside - DirectorsTalk Interviews
Chemed Corp - Reuters
Trading the Move, Not the Narrative: (CHE) Edition - Stock Traders Daily
Chemed Corporation (NYSE:CHE) Announces Quarterly Dividend of $0.60 - MarketBeat
Chemed Corp Stock (CHE) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.41%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):